A Rare Presentation of Metastatic Prostate Cancer With Recurrent Malignant Ascites: A Case Report and Literature Review

Peritoneal carcinomatosis with malignant ascites is a rare and aggressive presentation of advanced prostate cancer, often linked to a poor prognosis. Here, a case of a 58-year-old African American male presenting with ascites as the initial manifestation of prostate cancer is reported. Imaging revealed peritoneal carcinomatosis with concomitant pelvic lymph nodes and bone metastases. Cytologic analysis of the ascitic fluid confirmed prostate origin. The patient underwent androgen deprivation therapy and systemic chemotherapy with docetaxel followed by cabazitaxel. Despite treatment, the disease progressed rapidly with rising prostate-specific antigen levels and recurrent ascites, and he ultimately passed away 15 months after diagnosis. A literature review of similar cases is included, highlighting the poor clinical outcome posed by this rare presentation. Currently, there are no standardized guidelines for managing malignant ascites in prostate cancer. This case underscores the importance of multidisciplinary care addressing both oncologic and social factors. Further research is warranted to elucidate the mechanisms of peritoneal dissemination, improve early detection, and develop tailored therapeutic strategies for prostate cancer presenting with malignant ascites.

Authors

Institutions

Publication Details

Journal
Cureus
Published
2025-11-16
DOI
https://doi.org/10.7759/cureus.96993
Primary Topic
Prostate Cancer Treatment and Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

A Rare Presentation of Metastatic Prostate Cancer With Recurrent Malignant Ascites: A Case Report and Literature Review

Suki Gill, Mahtab Zangui, Edwin Chiu, Leen Khoury et al.
Cureus
Prostate Cancer Treatment and Research
article

A Rare Presentation of Metastatic Prostate Cancer With Recurrent Malignant Ascites: A Case Report and Literature Review

Suki Gill, Mahtab Zangui, Edwin Chiu, Leen Khoury, Yanming Wu, Mary Hanna
article en

Abstract

Peritoneal carcinomatosis with malignant ascites is a rare and aggressive presentation of advanced prostate cancer, often linked to a poor prognosis. Here, a case of a 58-year-old African American male presenting with ascites as the initial manifestation of prostate cancer is reported. Imaging revealed peritoneal carcinomatosis with concomitant pelvic lymph nodes and bone metastases. Cytologic analysis of the ascitic fluid confirmed prostate origin. The patient underwent androgen deprivation therapy and systemic chemotherapy with docetaxel followed by cabazitaxel. Despite treatment, the disease progressed rapidly with rising prostate-specific antigen levels and recurrent ascites, and he ultimately passed away 15 months after diagnosis. A literature review of similar cases is included, highlighting the poor clinical outcome posed by this rare presentation. Currently, there are no standardized guidelines for managing malignant ascites in prostate cancer. This case underscores the importance of multidisciplinary care addressing both oncologic and social factors. Further research is warranted to elucidate the mechanisms of peritoneal dissemination, improve early detection, and develop tailored therapeutic strategies for prostate cancer presenting with malignant ascites.

CureusVol. 17(11)
State University of New York (US), SUNY Downstate Health Sciences University (US)
Openalex Percentile: Top 50%
Prostate Cancer Treatment and Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.